Medicine
Clonidine 0.1 mg tablet
Clonidine 0.1 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Clonidine
- Brand
- Sold under the generic name
- Strength
- 0.1 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 500 tablets and 182 more
- Manufacturers
- Alembic PharmaceuticalsIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaBryant Ranch PrepackVerityrxMethod PharmaceuticalsTruPharmaActavis PharmaSolco Healthcare27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02AC01 Clonidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 September 1987
- Identifiers
- RxCUI 884173, 884185, 884189 +1DailyMed set ID e8c7aa08-1450-de68-e053-2995a90ad0b6, 0bde4636-7f34-467e-b9b9-8d281145177d, a842ab83-3531-44dd-a8a8-64dd89e87026 +37NDC 76420-283, 0615-2572, 0228-2127 +37Application ANDA070925, ANDA070974, ANDA078895 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 185 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 carton | 46708-306-10 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 30 tablet in 1 bottle | 46708-306-30 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 100 tablet in 1 bottle | 46708-306-31 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 500 tablet in 1 bottle | 46708-306-71 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 1000 tablet in 1 bottle | 46708-306-91 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 100 tablet in 1 carton | 62332-054-10 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 30 tablet in 1 bottle | 62332-054-30 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 100 tablet in 1 bottle | 62332-054-31 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 500 tablet in 1 bottle | 62332-054-71 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 1000 tablet in 1 bottle | 62332-054-91 | Alembic PharmaceuticalsIndia | 3 May 2016 |
| 100 tablet in 1 bottle | 59651-232-01 | Aurobindo PharmaIndia | 2 June 2021 |
| 1000 tablet in 1 bottle | 59651-232-99 | Aurobindo PharmaIndia | 2 June 2021 |
| 100 tablet in 1 bottle, plastic | 29300-468-01 | Unichem LaboratoriesIndia | 24 December 2020 |
| 500 tablet in 1 bottle, plastic | 29300-468-05 | Unichem LaboratoriesIndia | 24 December 2020 |
| 1000 tablet in 1 bottle, plastic | 29300-468-10 | Unichem LaboratoriesIndia | 24 December 2020 |
| 5000 tablet in 1 bottle, plastic | 29300-468-50 | Unichem LaboratoriesIndia | 24 December 2020 |
| 1 tablet in 1 pouch | 83939-0005-1 | Verityrx | 3 November 2025 |
| 50 pouch in 1 box, unit-dose / 1 tablet in 1 pouch | 83939-0005-2 | Verityrx | 3 November 2025 |
| 100 pouch in 1 box, unit-dose / 1 tablet in 1 pouch | 83939-0005-3 | Verityrx | 3 November 2025 |
| 1 tablet in 1 pouch | 83939-0006-1 | Verityrx | 3 November 2025 |
| 50 pouch in 1 box, unit-dose / 1 tablet in 1 pouch | 83939-0006-2 | Verityrx | 3 November 2025 |
| 100 pouch in 1 box, unit-dose / 1 tablet in 1 pouch | 83939-0006-3 | Verityrx | 3 November 2025 |
| 100 tablet in 1 bottle | 0228-2127-10 | Actavis Pharma | 3 January 1995 |
| 500 tablet in 1 bottle | 0228-2127-50 | Actavis Pharma | 3 January 1995 |
| 100 tablet in 1 bottle | 58657-647-01 | Method Pharmaceuticals | 1 July 2020 |
| 1000 tablet in 1 bottle | 58657-647-10 | Method Pharmaceuticals | 1 July 2020 |
| 500 tablet in 1 bottle | 58657-647-50 | Method Pharmaceuticals | 1 July 2020 |
| 100 tablet in 1 bottle, plastic | 43547-565-10 | Solco Healthcare | 5 January 2023 |
| 1000 tablet in 1 bottle, plastic | 43547-565-11 | Solco Healthcare | 5 January 2023 |
| 1000 tablet in 1 bottle | 52817-180-00 | TruPharma | 1 June 2017 |
| 100 tablet in 1 bottle | 52817-180-10 | TruPharma | 1 June 2017 |
| 500 tablet in 1 bottle | 52817-180-50 | TruPharma | 1 June 2017 |
| 500 tablet in 1 bottle | 63629-2314-1 | Bryant Ranch Prepack | 1 July 2020 |
| 100 tablet in 1 bottle | 63629-2315-1 | Bryant Ranch Prepack | 1 July 2020 |
| 24 tablet in 1 bottle | 71335-0777-0 | Bryant Ranch Prepack | 27 December 2021 |
| 100 tablet in 1 bottle | 71335-0777-1 | Bryant Ranch Prepack | 27 April 2018 |
| 30 tablet in 1 bottle | 71335-0777-2 | Bryant Ranch Prepack | 16 April 2018 |
| 20 tablet in 1 bottle | 71335-0777-3 | Bryant Ranch Prepack | 21 April 2021 |
| 60 tablet in 1 bottle | 71335-0777-4 | Bryant Ranch Prepack | 30 July 2018 |
| 120 tablet in 1 bottle | 71335-0777-5 | Bryant Ranch Prepack | 12 April 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 September 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Clonidine
Clinical summary
Clonidine is a central alpha-2 adrenergic agonist indicated in the treatment of hypertension. It is available as tablets, transdermal patches and extended-release tablets for oral and epidural use. MedsAcross supplies Clonidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClonidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clonidine Transdermal System USP, 0.1 mg/day prescribing information (TruPharma) · U.S. National Library of Medicine, DailyMed
Need Clonidine 0.1 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.